News

Adults with moderate atopic dermatitis reported rapid itch relief, better sleep, and improved daily functioning after eight weeks using Opzelura topical cream.

Sunlight can be both harmful and beneficial, meaning it’s important for dermatologists to give personalized advice to each patient, according to this morning’s 2026 American Academy of Dermatology session

A new patient survey reveals gaps in treatment persistence and awareness among patients with vitiligo.

Lack of measures that take into account severity hinders participation by dermatologists, says the University of Iowa Health Care dermatologic surgeon.

Arthropods can cause or mimic a wide range of skin diseases, making accurate recognition, diagnosis and management essential in dermatologic care.

This afternoon’s session emphasized evolving vitiligo management strategies focused on emerging immune-targeted treatments, alongside a growing emphasis on holistic, patient-centered care.

The large dose of brepocitinib, a JAK1/TYK2 inhibitor, showed benefits on a composite score and secondary end points. The FDA has set a PDUFA date for the drug in the third quarter of 2026, according to its developer.

At the American Academy of Dermatology 2026 meeting, dermatology leaders emphasized the growing need for advocacy to address rural access disparities and the escalating impact of climate change on patient care and health systems.

Barbieri, director of the Advanced Acne Therapeutics Clinic at Brigham and Women's Hospital in Boston, discusses the complexities of figuring out cost-effect acne treatment.

The 2026 American Academy of Dermatology meeting began today in Denver, featuring a keynote conversation this evening with John Legend on wellness, identity and his Loved01 skincare brand.

Studies have shown that routine monitoring for hyperkalemia has limited usefulness, says Barbieri, director of the Advanced Acne Therapeutics Clinic at Brigham and Women's Hospital in Boston.

Barbieri, director of the Advanced Acne Therapeutics Clinic at Brigham and Women's Hospital in Boston, provided an update on spironolactone at the American Academy of Dermatology meeting in Denver.

CEO of Veradermics, Reid Waldman, M.D., shared that faster hair growth and shifting patient views on prescription treatments could play a key role in improving adherence and outcomes for pattern hair loss.

At the 2026 American Academy of Dermatology meeting, Reid Waldman, M.D., shared data showing that Veradermics’ investigational oral drug VDPHL01 produced faster, more consistent and greater hair growth than existing minoxidil treatments.

Vitiligo is a chronic autoimmune disease that affects skin pigmentation and, while not painful or contagious, requires greater attention in managed care due to its long-term nature and psychosocial impact.

Nearly half of patients skip care when costs are unclear. Although price estimates are improving, affordability and financial anxiety remain major barriers to accessing healthcare.

A new JAMA study compares the U.S. and South Korea, revealing sharper income-driven gaps in access, spending and outcomes, and why policy fixes matter.

In a "low mitigation" scenario, work requirements and redetermination every six months would mean a 55% decline in projected 2028 Medicaid enrollment, from 18.4 million to 8.3 million.

Results of a study done at Cedars-Sinai Medical Center in Los Angeles and Brigham and Women's Hospital in Boston suggest that older patients with low medication adherence and literacy might benefit from a pharmacist-led medication management as they are leaving the hospital.

Jefferson health and Ipendence Blue Cross are working together to improve early dementia detection and care coordination in primary care, helping patients receive support sooner and stay healthier at home

Eli Lilly's once-daily oral GLP-1, orforglipron, awaits FDA approval in April 2026. New research shows orforglipron outperforms oral semaglutide for lowering A1C and for weight loss.

Pharmacists have the training and are employed by the health system so it makes sense to put them in charge of postdischarge medication planning and management

Joshua M. Pevnick, M.D., M.S.H.S., discusses medications and the risk of an adverse drug event among older people after they get discharged from the hospital.

A childhood teacher once told Rachel Moseley, Ph.D., there was “no point” in teaching her math. Since then, she has graduated from Cambridge University in England with a doctorate in cognitive neuroscience. She and a colleague have recently published a book of interviews exploring menopause among people with autism.

UnitedHealthcare is expanding access to doula services through eligible employer-sponsored plans, aiming to improve maternal health outcomes and provide more comprehensive pregnancy support.